2012 infectious diseases society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections

Clinical Infectious Diseases

Volumn 54, Issue 12, 2012, Pages

  Lipsky, Benjamin A ^a   Berendt, Anthony R ^b   Cornia, Paul B ^c   Pile, James C ^d   Peters, Edgar J G ^e   Armstrong, David G ^f   Deery, H Gunner ^g   Embil, John M ^h   Joseph, Warren S ⁱ   Karchmer, Adolf W ^j   Pinzur, Michael S ^k   Senneville, Eric ^l  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^c UNIVERSITY OF WASHINGTON   (United States)

^d METROHEALTH MEDICAL CENTER   (United States)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF ARIZONA   (United States)

^g Northern Michigan Infectious Diseases   (United States)

^h UNIVERSITY OF MANITOBA   (Canada)

ⁱ Roxborough Memorial Hospital   (United States)

^j BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^k LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^l Dron Hospital   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; C REACTIVE PROTEIN; CEFALEXIN; CEFOXITIN; CEFTAZIDIME; CEFTOBIPROLE; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CLAVULANATE POTASSIUM PLUS TICARCILLIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; DICLOXACILLIN; DOXYCYCLINE; ERTAPENEM; LEVOFLOXACIN; LINEZOLID; METRONIDAZOLE; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; PEXIGANAN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TIGECYCLINE; UNINDEXED DRUG; VANCOMYCIN;

ANAMNESIS; ANTIBIOTIC THERAPY; BONE BIOPSY; CONSULTATION; DEBRIDEMENT; DIABETIC FOOT; DIABETIC FOOT INFECTION; DIABETIC FOOT OSTEOMYELITIS; DIABETIC PATIENT; DISEASE CLASSIFICATION; DRUG WITHDRAWAL; FOLLOW UP; FOOT AMPUTATION; FOOT DISEASE; FOOT RADIOGRAPHY; HOSPITALIZATION; HUMAN; HYPERBARIC OXYGEN; MEDICAL SOCIETY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; REVASCULARIZATION; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; VOMITING;

ANTI-BACTERIAL AGENTS; BACTERIA; COMMUNICABLE DISEASES; DEBRIDEMENT; DIABETIC FOOT; HUMANS; INFLAMMATION; SUPPURATION;

EID: 84861510108     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis346     Document Type: Review

References (345)

1. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336:924-6. (Pubitemid 351632017)
2. Guyatt GH, Oxman AD, Kunz R, et al. Going from evidence to recommendations. BMJ 2008; 336:1049-51.
3. Jaeschke R, Guyatt GH, Dellinger P, et al. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ 2008; 337:a744.
4. Kish MA. Guide to development of practice guidelines. Clin Infect Dis 2001; 32:851-4. (Pubitemid 32524817)
5. Schunemann HJ, Oxman AD, Brozek J, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 2008; 336:1106-10. (Pubitemid 351731739)
6. Guyatt GH, Oxman AD, Kunz R, et al. Incorporating considerations of resources use into grading recommendations. BMJ 2008; 336:1170-3. (Pubitemid 351809277)
7. Centers for Disease Control and Prevention. Number (in thousands) of hospital discharges with ulcer/inflammation/infection (ULCER) as first-listed diagnosis and diabetes as any-listed diagnosis, 1980-2003. 2010. Available at: http://www.cdc.gov/diabetes/statistics/hosplea/diabetes-complications/fig5.htm.
8. Centers for Disease Control and Prevention. Number (in thousands) of hospital discharges for non-traumatic lower extremity amputation with diabetes as a listed diagnosis, 1988-2006. CDC, 2010. Available at: http://www.cdc.gov/ diabetes/statistics/lea/fig1.htm.
9. Prevention. Age-adjusted hospital discharge rates for non-traumatic lower extremity amputation per 1,000 diabetic population, by level of amputation. CDC, 2010. Available at: http://www.cdc.gov/diabetes/statistics/lealevel/fig8. htm.
10. Vamos EP, Bottle A, Majeed A, Millett C. Trends in lower extremity amputations in people with and without diabetes in England, 1996-2005. Diabetes Res Clin Pract 2010; 87:275-82.
11. Armstrong DG, Wrobel J, Robbins JM. Guest editorial: are diabetesrelated wounds and amputations worse than cancer? Int Wound J 2007; 4:286-7. (Pubitemid 350264806)
12. Richard JL, Lavigne JP, Got I, et al. Management of patients hospitalized for diabetic foot infection: results of the French OPIDIA study. Diabetes Metab 2010; 37:208-15.
13. Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007; 50:18-25. (Pubitemid 46035847)
14. Prompers L, Schaper N, Apelqvist J, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia 2008; 51:747-55.
15. van Battum P, Schaper N, Prompers L, et al. Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation. Diabet Med 2011; 28:199-205.
16. Prompers L, Huijberts M, Schaper N, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale study. Diabetologia 2008; 51:1826-34.
17. Prompers L, Huijberts M, Apelqvist J, et al. Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale study, a prospective cohort study. Diabet Med 2008; 25:700-7. (Pubitemid 351782831)
18. Gottrup F, Holstein P, Jorgensen B, Lohmann M, Karlsmar T. A new concept of a multidisciplinary wound healing center and a national expert function of wound healing. Arch Surg 2001; 136:765-72. (Pubitemid 32642795)
19. Trautner C, Haastert B, Mauckner P, Gatcke LM, Giani G. Reduced incidence of lower-limb amputations in the diabetic population of a German city, 1990-2005: results of the Leverkusen Amputation Reduction Study (LARS). Diabetes Care 2007; 30:2633-7. (Pubitemid 47547809)
20. Krishnan S, Nash F, Baker N, Fowler D, Rayman G. Reduction in diabetic amputations over 11 years in a defined U.K. population: benefits of multidisciplinary team work and continuous prospective audit. Diabetes Care 2008; 31:99-101.
21. Hellingman AA, Smeets HJ. Efficacy and efficiency of a streamlined multidisciplinary foot ulcer service. J Wound Care 2008; 17:541-4.
22. Rerkasem K, Kosachunhanun N, Tongprasert S, et al. Reducing lower extremity amputations due to diabetes: the application of diabetic-foot protocol in Chiang Mai University Hospital. Int J low Extrem Wounds 2008; 7:88-92. (Pubitemid 351678181)
23. Ortegon MM, Redekop WK, Niessen LW. Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis. Diabetes Care 2004; 27:901-7. (Pubitemid 38420212)
24. Tan T, Shaw EJ, Siddiqui F, Kandaswamy P, Barry PW, Baker M. Inpatient management of diabetic foot problems: summary of NICE guidance. BMJ 2011; 342:d1280.
25. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293:217-28. (Pubitemid 40095873)
26. Haller NA, Gil KM, Gardner WG, Whittier FC. Patient computer use to prompt doctor adherence to diabetes management guidelines. J Eval Clin Pract 2009; 15:1118-24.
27. Field MJ, Lohr KN; Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines. Clinical Practice Guidelines: directions for a new program. Washington, DC: National Academies Press, 1990:52-77.
28. Guyatt GH, Cook DJ, Jaeschke R, Pauker SG, Schunemann HJ. Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th ed. Chest 2008; 133:123S-31S.
29. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is "quality of evidence" and why is it important to clinicians? BMJ 2008; 336:995-8. (Pubitemid 351656090)
30. Cutting KF, White R. Defined and refined: criteria for identifying wound infection revisited. Br J Community Nurs 2004; 9:S6-15.
31. Gardner SE, Hillis SL, Frantz RA. Clinical signs of infection in diabetic foot ulcers with high microbial load. Biol Res Nurs 2009; 11:119-28.
32. Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care 2006; 29:1288-93. (Pubitemid 44125924)
33. Peters EJ, Lavery LA, Armstrong DG. Diabetic lower extremity infection: influence of physical, psychological, and social factors. J Diabetes Complications 2005; 19:107-12. (Pubitemid 40312624)
34. Bartos V, Jirkovska A, Koznarova R. [Risk factors for diabetic foot in recipients of renal and pancreatic transplants]. Cas Lek Cesk 1997; 136:527-9.
35. George RK, Verma AK, Agarwal A, Agarwal G, Mishra SK. An audit of foot infections in patients with diabetes mellitus following renal transplantation. Int J low Extrem Wounds 2004; 3:157-60.
36. Hill MN, Feldman HI, Hilton SC, Holechek MJ, Ylitalo M, Benedict GW. Risk of foot complications in long-term diabetic patients with and without ESRD: a preliminary study. ANNA J 1996; 23:381-6; discussion 87-8.
37. Jayasinghe SA, Atukorala I, Gunethilleke B, Siriwardena V, Herath SC, De Abrew K. Is walking barefoot a risk factor for diabetic foot disease in developing countries? Rural Remote Health 2007; 7:692.
38. Karthikesalingam A, Holt PJ, Moxey P, Jones KG, Thompson MM, Hinchliffe RJ. A systematic review of scoring systems for diabetic foot ulcers. Diabet Med 2010; 27:544-9.
39. Schaper NC. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev 2004; 20,suppl. 1:S90-5. (Pubitemid 38714342)
40. Meggitt B. Surgical management of the diabetic foot. Br J Hosp Med 1976; 16:227-332.
41. Ince P, Abbas ZG, Lutale JK, et al. Use of the SINBAD classification system and score in comparing outcome of foot ulcer management on three continents. Diabetes Care 2008; 31:964-7.
42. Lavery LA, Armstrong DG, Murdoch DP, Peters EJ, Lipsky BA. Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis 2007; 44:562-5. (Pubitemid 46233260)
43. Jeandrot A, Richard JL, Combescure C, et al. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study. Diabetologia 2008; 51:347-52.
44. Wagner FW Jr. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 1981; 2:64-122. (Pubitemid 12170741)
45. Treece KA, Macfarlane RM, Pound N, Game FL, Jeffcoate WJ. Validation of a system of foot ulcer classification in diabetes mellitus. Diabet Med 2004; 21:987-91. (Pubitemid 39215318)
46. Ince P, Kendrick D, Game F, Jeffcoate W. The association between baseline characteristics and the outcome of foot lesions in a UK population with diabetes. Diabet Med 2007; 24:977-81. (Pubitemid 47301636)
47. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 1998; 21:855-9. (Pubitemid 28487086)
48. Parisi MC, Zantut-Wittmann DE, Pavin EJ, Machado H, Nery M, Jeffcoate WJ. Comparison of three systems of classification in predicting the outcome of diabetic foot ulcers in a Brazilian population. Eur J Endocrinol 2008; 159:417-22.
49. Knighton DR, Ciresi KF, Fiegel VD, Austin LL, Butler EL. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 1986; 204:322-30. (Pubitemid 16014252)
50. Beckert S, Witte M, Wicke C, Konigsrainer A, Coerper S. A new wound-based severity score for diabetic foot ulcers: a prospective analysis of 1,000 patients. Diabetes Care 2006; 29:988-92. (Pubitemid 44115232)
51. Beckert S, Pietsch AM, Kuper M, et al. M.A.I.D.: a prognostic score estimating probability of healing in chronic lower extremity wounds. Ann Surg 2009; 249:677-81.
52. Lipsky BA, Polis AB, Lantz KC, Norquist JM, Abramson MA. The value of a wound score for diabetic foot infections in predicting treatment outcome: a prospective analysis from the SIDESTEP trial. Wound Repair Regen 2009; 17:671-7.
53. Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004; 39:885-910. (Pubitemid 39328144)
54. Schaper NC, Apelqvist J, Bakker K. The international consensus and practical guidelines on the management and prevention of the diabetic foot. Curr Diab Rep 2003; 3:475-9. (Pubitemid 38906808)
55. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003; 26:510-3. (Pubitemid 36929083)
56. Vedhara K, Miles JN, Wetherell MA, et al. Coping style and depression influence the healing of diabetic foot ulcers: observational and mechanistic evidence. Diabetologia 2010; 53:1590-8.
57. Uzun G, Solmazgul E, Curuksulu H, et al. Procalcitonin as a diagnostic aid in diabetic foot infections. Tohoku J Exp Med 2007; 213:305-12.
58. Lipsky BA, Sheehan P, Armstrong DG, Tice AD, Polis AB, Abramson MA. Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial. Int Wound J 2007; 4:30-8.
59. Akinci B, Yener S, Yesil S, Yapar N, Kucukyavas Y, Bayraktar F. Acute phase reactants predict the risk of amputation in diabetic foot infection. J Am Podiatr Med Assoc 2011; 101:1-6.
60. Peripheral arterial disease in people with diabetes. Diabetes Care 2003; 26:3333-41.
61. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113: e463-654.
62. van Baal JG. Surgical treatment of the infected diabetic foot. Clin Infect Dis 2004; 39(Suppl 2):S123-8. (Pubitemid 39050508)
63. Pinzur MS, Pinto MA, Schon LC, Smith DG. Controversies in amputation surgery. Instr Course Lect 2003; 52:445-51.
64. Khan NA, Rahim SA, Anand SS, Simel DL, Panju A. Does the clinical examination predict lower extremity peripheral arterial disease? JAMA 2006; 295:536-46. (Pubitemid 43200348)
65. Wilson JF, Laine C, Goldmann D. In the clinic. Peripheral arterial disease. Ann Intern Med 2007; 146:ITC3-1-ITC3-16.
66. Crane M, Werber B. Critical pathway approach to diabetic pedal infections in a multidisciplinary setting. J Foot Ankle Surg 1999; 38:30-3; discussion 82-3. (Pubitemid 29081282)
67. Larsson J, Apelqvist J, Agardh CD, Stenstrom A. Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach? Diabet Med 1995; 12:770-6.
68. Dargis V, Pantelejeva O, Jonushaite A, Vileikyte L, Boulton AJ. Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care 1999; 22:1428-31. (Pubitemid 29418234)
69. Fitzgerald RH, Mills JL, Joseph W, Armstrong DG. The diabetic rapid response acute foot team: 7 essential skills for targeted limb salvage. Eplasty 2009; 9:e15.
70. Gibbons GW. Lower extremity bypass in patients with diabetic foot ulcers. Surg Clin North Am 2003; 83:659-69. (Pubitemid 36687719)
71. Bus SA, Hazenberg CE, Klein M, Van Baal JG. Assessment of foot disease in the home environment of diabetic patients using a new photographic foot imaging device. J Med Eng Technol 2010; 34:43-50.
72. Clemensen J, Larsen SB, Ejskjaer N. Telemedical treatment at home of diabetic foot ulcers. J Telemed Telecare 2005; 11(Suppl 2):S14-6.
73. Bowling FL, King L, Paterson JA, et al. Remote assessment of diabetic foot ulcers using a novel wound imaging system. Wound Repair Regen 2011; 19:25-30.
74. Wilbright WA, Birke JA, Patout CA, Varnado M, Horswell R. The use of telemedicine in the management of diabetes-related foot ulceration: a pilot study. Adv Skin Wound Care 2004; 17:232-8.
75. Aragon-Sanchez J. Seminar review: a review of the basis of surgical treatment of diabetic foot infections. Int J Low Extrem Wounds 2011; 10:33-65.
76. Sumpio BE, Armstrong DG, Lavery LA, Andros G. The role of interdisciplinary team approach in the management of the diabetic foot: a joint statement from the Society for Vascular Surgery and the American Podiatric Medical Association. J Vasc Surg 2010; 51:1504-6.
77. Akbari CM, Pomposelli FB Jr, Gibbons GW, et al. Lower extremity revascularization in diabetes: late observations. Arch Surg 2000; 135:452-6. (Pubitemid 30198516)
78. Lipsky BA, Pecoraro RE, Larson SA, Hanley ME, Ahroni JH. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med 1990; 150:790-7. (Pubitemid 20122055)
79. Lipsky BA, Itani K, Norden C. Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. Clin Infect Dis 2004; 38:17-24. (Pubitemid 38045868)
80. Armstrong DG, Lavery LA, Sariaya M, Ashry H. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg 1996; 35:280-3. (Pubitemid 26299122)
81. Eneroth M, Larsson J, Apelqvist J. Deep foot infections in patients with diabetes and foot ulcer: an entity with different characteristics, treatments, and prognosis. J Diabetes Complications 1999; 13:254-63. (Pubitemid 30182605)
82. Frykberg RG. An evidence-based approach to diabetic foot infections. Am J Surg 2003; 186:44S-54S; discussion 61S-64S. (Pubitemid 37548489)
83. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994; 331:854-60.
84. No authors listed. Consensus Development Conference on Diabetic Foot Wound Care: 7-8 April 1999, Boston, Massachusetts. American Diabetes Association. Diabetes Care 1999; 22:1354-60.
85. Rao N, Lipsky BA. Optimising antimicrobial therapy in diabetic foot infections. Drugs 2007; 67:195-214.
86. Dang CN, Prasad YD, Boulton AJ, Jude EB. Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med 2003; 20:159-61. (Pubitemid 36269659)
87. Stanaway S, Johnson D, Moulik P, Gill G. Methicillin-resistant Staphylococcus aureus (MRSA) isolation from diabetic foot ulcers correlates with nasal MRSA carriage. Diabetes Res Clin Pract 2007; 75:47-50. (Pubitemid 44856029)
88. Carvalho CB, Neto RM, Aragao LP, Oliveira MM, Nogueira MB, Forti AC. [Diabetic foot infection. Bacteriologic analysis of 141 patients]. Arq Bras Endocrinol Metabol 2004; 48:398-405.
89. Shankar EM, Mohan V, Premalatha G, Srinivasan RS, Usha AR. Bacterial etiology of diabetic foot infections in South India. Eur J Intern Med 2005; 16:567-70. (Pubitemid 41728210)
90. Tascini C, Gemignani G, Palumbo F, et al. Clinical and microbiological efficacy of colistin therapy alone or in combination as treatment for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or without osteomyelitis. J Chemother 2006; 18:648-51. (Pubitemid 46045396)
91. Kandemir O, Akbay E, Sahin E, Milcan A, Gen R. Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms. J Infect 2007; 54:439-45. (Pubitemid 46567506)
92. Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 2006; 29:1727-32. (Pubitemid 44156621)
93. Edmonds M. Infection in the neuroischemic foot. Int J low Extrem Wounds 2005; 4:145-53. (Pubitemid 41437581)
94. Richard JL, Sotto A, Jourdan N, et al. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers. Diabetes Metab 2008; 34:363-9.
95. Sotto A, Richard JL, Jourdan N, Combescure C, Bouziges N, Lavigne JP. Miniaturized oligonucleotide arrays: a new tool for discriminating colonization from infection due to Staphylococcus aureus in diabetic foot ulcers. Diabetes Care 2007; 30:2051-6. (Pubitemid 47219419)
96. Chakraborti C, Le C, Yanofsky A. Sensitivity of superficial cultures in lower extremity wounds. J Hosp Med 2010; 5:415-20.
97. Gardner SE, Frantz RA, Saltzman CL, Hillis SL, Park H, Scherubel M. Diagnostic validity of three swab techniques for identifying chronic wound infection. Wound Repair Regen 2006; 14:548-57. (Pubitemid 44470071)
98. Nelson EA, O'Meara S, Craig D, et al. A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers. Health Technol Assess 2006; 10:iii-iv, ix-x, 1-221.
99. Singh SK, Gupta K, Tiwari S, et al. Detecting aerobic bacterial diversity in patients with diabetic foot wounds using ERIC-PCR: a preliminary communication. Int J Low Extrem Wounds 2009; 8:203-8.
100. Fisher TK, Wolcott R, Wolk DM, Bharara M, Kimbriel HR, Armstrong DG. Diabetic foot infections: a need for innovative assessments. Int J Low Extrem Wounds 2010; 9:31-6.
101. Sotto A, Lina G, Richard JL, et al. Virulence potential of Staphylococcus aureus strains isolated from diabetic foot ulcers: a new paradigm. Diabetes Care 2008; 31:2318-24.
102. Wolcott RD, Cox SB, Dowd SE. Healing and healing rates of chronic wounds in the age of molecular pathogen diagnostics. J Wound Care 2010; 19:272-8, 80-1.
103. Hirschl M, Hirschl AM. Bacterial flora in mal perforant and antimicrobial treatment with ceftriaxone. Chemotherapy 1992; 38:275-80.
104. Chantelau E, Tanudjaja T, Altenhofer F, Ersanli Z, Lacigova S, Metzger C. Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial. Diabet Med 1996; 13:156-9. (Pubitemid 26074293)
105. Edmonds M, Foster A. The use of antibiotics in the diabetic foot. Am J Surg 2004; 187:25S-28S. (Pubitemid 38625984)
106. Gardner SE, Frantz RA. Wound bioburden and infection-related complications in diabetic foot ulcers. Biol Res Nurs 2008; 10:44-53.
107. Ramakant P, Verma AK, Misra R, et al. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia 2011; 54:58-64.
108. Lipsky BA. Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection? Clin Microbiol Infect 2007; 13:351-3. (Pubitemid 46390219)
109. Wheat LJ, Allen SD, Henry M, et al. Diabetic foot infections. Bacteriologic analysis. Arch Intern Med 1986; 146:1935-40.
110. Krikava K, Pospisil M. [The diabetic foot syndrome-antibiotic therapy]. Rozhl Chir 1999; 78:295-8.
111. Ng LS, Kwang LL, Yeow SC, Tan TY. Anaerobic culture of diabetic foot infections: organisms and antimicrobial susceptibilities. Ann Acad Med Singapore 2008; 37:936-9.
112. Dowd SE, Wolcott RD, Sun Y, McKeehan T, Smith E, Rhoads D. Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One 2008; 3:e3326.
113. Armstrong DG, Liswood PJ, Todd WF, William J. Stickel Bronze Award. Prevalence of mixed infections in the diabetic pedal wound. A retrospective review of 112 infections. J Am Podiatr Med Assoc 1995; 85:533-7.
114. Lipsky BA, Holroyd KJ, Zasloff M. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clin Infect Dis 2008; 47:1537-45.
115. Lipsky BA, Hoey C. Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis 2009; 49:1541-9.
116. Lipsky BA, McDonald D, Litka P. Treatment of infected diabetic foot ulcers: topical MSI-78 vs. oral ofloxacin. Diabetologia 1997; 40:482.
117. Noel GJ, Strauss RS, Amsler K, Heep M, Pypstra R, Solomkin JS. Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by grampositive bacteria. Antimicrob Agents Chemother 2008; 52:37-44.
118. Noel GJ, Bush K, Bagchi P, Ianus J, Strauss RS. A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections. Clin Infect Dis 2008; 46:647-55. (Pubitemid 351321545)
119. Graham DR, Lucasti C, Malafaia O, et al. Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study. Clin Infect Dis 2002; 34:1460-8. (Pubitemid 34553705)
120. Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA. Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 2005; 366:1695-703. (Pubitemid 41587448)
121. Ertugrul MB, Baktiroglu S, Salman S, et al. Pathogens isolated from deep soft tissue and bone in patients with diabetic foot infections. J Am Podiatr Med Assoc 2008; 98:290-5.
122. Martinez-Gomez Dde A, Ramirez-Almagro C, Campillo-Soto A, Morales-Cuenca G, Pagan-Ortiz J, Aguayo-Albasini JL. [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms]. Enferm Infecc Microbiol Clin 2009; 27:317-21.
123. Bansal E, Garg A, Bhatia S, Attri AK, Chander J. Spectrum of microbial flora in diabetic foot ulcers. Indian J Pathol Microbiol 2008; 51:204-8. (Pubitemid 351961358)
124. Yoga R, Khairul A, Sunita K, Suresh C. Bacteriology of diabetic foot lesions. Med J Malaysia 2006; 61(Suppl A):14-6. (Pubitemid 44196909)
125. Shakil S, Khan AU. Infected foot ulcers in male and female diabetic patients: a clinico-bioinformative study. Ann Clin Microbiol Antimicrob 2010; 9:2.
126. Wang SH, Sun ZL, Guo YJ, et al. Meticillin-resistant Staphylococcus aureus isolated from foot ulcers in diabetic patients in a Chinese care hospital: risk factors for infection and prevalence. J Med Microbiol 2010; 59:1219-24.
127. Tentolouris N, Petrikkos G, Vallianou N, et al. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect 2006; 12:186-9. (Pubitemid 43379350)
128. Yates C, May K, Hale T, et al. Wound chronicity, inpatient care, and chronic kidney disease predispose to MRSA infection in diabetic foot ulcers. Diabetes Care 2009; 32:1907-9.
129. Vardakas KZ, Horianopoulou M, Falagas ME. Factors associated with treatment failure in patients with diabetic foot infections: an analysis of data from randomized controlled trials. Diabetes Res Clin Pract 2008; 80:344-51.
130. Arbeit RD, Maki D, Tally FP, Campanaro E, Eisenstein BI. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 2004; 38:1673-81. (Pubitemid 38781657)
131. Eleftheriadou I, Tentolouris N, Argiana V, Jude E, Boulton AJ. Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs 2010; 70:1785-97.
132. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin- resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18-55.
133. David MZ, Glikman D, Crawford SE, et al. What is communityassociated methicillin-resistant Staphylococcus aureus? J Infect Dis 2008; 197:1235-43. (Pubitemid 351632754)
134. Lagace-Wiens PR, Ormiston D, Nicolle LE, Hilderman T, Embil J. The diabetic foot clinic: not a significant source for acquisition of methicillin-resistant Staphylococcus aureus. Am J Infect Control 2009; 37:587-9.
135. Raymakers JT, Schaper NC, van der Heyden JJ, Tordoir JH, Kitslaar PJ. Penetration of ceftazidime into bone from severely ischaemic limbs. J Antimicrob Chemother 1998; 42:543-5. (Pubitemid 28473019)
136. Seabrook GR, Edmiston CE, Schmitt DD, Krepel C, Bandyk DF, Towne JB. Comparison of serum and tissue antibiotic levels in diabetes-related foot infections. Surgery 1991; 110:671-6; discussion 76-7.
137. Duckworth C, Fisher JF, Carter SA, et al. Tissue penetration of clindamycin in diabetic foot infections. J Antimicrob Chemother 1993; 31:581-4. (Pubitemid 23150136)
138. Legat FJ, Maier A, Dittrich P, et al. Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome. Antimicrob Agents Chemother 2003; 47:371-4. (Pubitemid 36070388)
139. Muller M, Brunner M, Hollenstein U, et al. Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in noninsulin-dependent diabetes mellitus patients. Antimicrob Agents Chemother 1999; 43:2056-8. (Pubitemid 29395209)
140. Kuck EM, Bouter KP, Hoekstra JB, Conemans JM, Diepersloot RJ. Tissue concentrations after a single-dose, orally administered ofloxacin in patients with diabetic foot infections. Foot Ankle Int 1998; 19: 38-40. (Pubitemid 28065163)
141. Mueller-Buehl U, Diehm C, Gutzler F, Adam D. Tissue concentrations of ofloxacin in necrotic foot lesions of diabetic and non-diabetic patients with peripheral arterial occlusive disease. Vasa 1991; 20:17-21.
142. Traunmuller F, Schintler MV, Metzler J, et al. Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections. J Antimicrob Chemother 2010; 65:1252-7.
143. Schintler MV, Traunmuller F, Metzler J, et al. High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection. J Antimicrob Chemother 2009; 64:574-8.
144. Majcher-Peszynska J, Haase G, Sass M, et al. Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections. Eur J Clin Pharmacol 2008; 64:1093-100.
145. Nicolau DP, Stein GE. Therapeutic options for diabetic foot infections: a review with an emphasis on tissue penetration characteristics. J Am Podiatr Med Assoc 2010; 100:52-63.
146. Raymakers JT, Houben AJ, van der Heyden JJ, Tordoir JH, Kitslaar PJSchaper NC. The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb. Diabet Med 2001; 18:229-34. (Pubitemid 32397862)
147. Deresinski SC. The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials. Diagn Microbiol Infect Dis 2008; 61:103-9. (Pubitemid 351509757)
148. Lipsky BA, Giordano P, Choudhri S, Song J. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate. J Antimicrob Chemother 2007; 60:370-6. (Pubitemid 47243888)
149. Harkless L, Boghossian J, Pollak R, et al. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers. Surg Infect (Larchmt) 2005; 6:27-40. (Pubitemid 40711363)
150. Clay PG, Graham MR, Lindsey CC, Lamp KC, Freeman C, Glaros A. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males. Am J Geriatr Pharmacother 2004; 2:181-9. (Pubitemid 39618443)
151. Lobmann R, Ambrosch A, Seewald M, et al. Antibiotic therapy for diabetic foot infections: comparison of cephalosporines with chinolones. Diabetes Nutr Metab 2004; 17:156-62. (Pubitemid 39117276)
152. Vick-Fragoso R, Hernandez-Oliva G, Cruz-Alcazar J, et al. Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections. Infection 2009; 37:407-17.
153. Griffis CD, Metcalfe S, Bowling FL, Boulton AJ, Armstrong DG. The use of gentamycin-impregnated foam in the management of diabetic foot infections: a promising delivery system? Expert Opin Drug Deliv 2009; 6:639-42.
154. Salgami EV, Bowling FL, Whitehouse RW, Boulton AJ. Use of tobramycin-impregnated calcium sulphate pellets in addition to oral antibiotics: an alternative treatment to minor amputation in a case of diabetic foot osteomyelitis. Diabetes Care 2007; 30:181-2. (Pubitemid 46052523)
155. Lipsky BA, Stoutenburgh U. Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections. J Antimicrob Chemother 2005; 55:240-5. (Pubitemid 40331152)
156. Sabol M. Phase 3 study: evaluating the safety and efficacy of a oncedaily dose of tigecycline and ertapenem in diabetic foot infections with a substudy in patients with diabetic foot infections complicated by osteomyelitis. 2009; Clinical Trials Identifier Number: NCT00366249.
157. Saltoglu N, Dalkiran A, Tetiker T, et al. Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital. Clin Microbiol Infect 2010; 16:1252-7.
158. No authors listed. Study evaluating the safety and efficacy of a oncedaily dose of tigecycline vs ertapenem in diabetic foot infections (DFI) with a substudy in patients with diabetic foot infections complicated by osteomyelitis. 2010.
159. Lipsky BA. Evidence-based antibiotic therapy of diabetic foot infections. FEMS Immunol Med Microbiol 1999; 26:267-76.
160. No authors listed. Guidance for industry. Acute bacterial skin and skin structure infections: developing drugs for treatment DRAFT GUIDANCE. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) 2010; Docket Number HFA-305:1-35.
161. Crouzet J, Lavigne JP, Richard JL, Sotto A. Diabetic foot infection: a critical review of recent randomized clinical trials on antibiotic therapy. Int J Infect Dis 2011; 15:e601-10.
162. Dinh MT, Abad CL, Safdar N. Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis. Clin Infect Dis 2008; 47:519-27.
163. Shults DW, Hunter GC, McIntyre KE, Parent FN, Piotrowski JJ, Bernhard VM. Value of radiographs and bone scans in determining the need for therapy in diabetic patients with foot ulcers. Am J Surg 1989; 158:525-9; discussion 29-30.
164. Butalia S, Palda VA, Sargeant RJ, Detsky AS, Mourad O. Does this patient with diabetes have osteomyelitis of the lower extremity? JAMA 2008; 299:806-13. (Pubitemid 351281574)
165. Jeffcoate WJ, Lipsky BA. Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis 2004; 39(Suppl 2):S115-22. (Pubitemid 39050507)
166. Kapoor A, Page S, Lavalley M, Gale DR, Felson DT. Magnetic resonance imaging for diagnosing foot osteomyelitis: a meta-analysis. Arch Intern Med 2007; 167:125-32. (Pubitemid 46148059)
167. Ledermann HP, Morrison WB, Schweitzer ME. Pedal abscesses in patients suspected of having pedal osteomyelitis: analysis with MR imaging. Radiology 2002; 224:649-55. (Pubitemid 34919793)
168. Ledermann HP, Schweitzer ME, Morrison WB. Nonenhancing tissue on MR imaging of pedal infection: characterization of necrotic tissue and associated limitations for diagnosis of osteomyelitis and abscess. AJR Am J Roentgenol 2002; 178:215-22. (Pubitemid 34016404)
169. Schweitzer ME, Morrison WB. MR imaging of the diabetic foot. Radiol Clin North Am 2004; 42:61-71, vi. (Pubitemid 38283556)
170. Tan PL, Teh J. MRI of the diabetic foot: differentiation of infection from neuropathic change. Br J Radiol 2007; 80:939-48. (Pubitemid 350206225)
171. Tomas MB, Patel M, Marwin SE, Palestro CJ. The diabetic foot. Br J Radiol 2000; 73:443-50. (Pubitemid 30251358)
172. Armstrong DG, Harkless LB. Outcomes of preventative care in a diabetic foot specialty clinic. J Foot Ankle Surg 1998; 37:460-6. (Pubitemid 29024109)
173. Becker W. Imaging osteomyelitis and the diabetic foot. Q J Nucl Med 1999; 43:9-20. (Pubitemid 29183009)
174. Palestro CJ, Love C. Nuclear medicine and diabetic foot infections. Semin Nucl Med 2009; 39:52-65.
175. Delcourt A, Huglo D, Prangere T, et al. Comparison between Leukoscan (Sulesomab) and Gallium-67 for the diagnosis of osteomyelitis in the diabetic foot. Diabetes Metab 2005; 31:125-33. (Pubitemid 40577196)
176. Schweitzer ME, Daffner RH, Weissman BN, et al. ACR Appropriateness criteria on suspected osteomyelitis in patients with diabetes mellitus. J Am Coll Radiol 2008; 5:881-6. (Pubitemid 352020699)
177. Enderle MD, Coerper S, Schweizer HP, et al. Correlation of imaging techniques to histopathology in patients with diabetic foot syndrome and clinical suspicion of chronic osteomyelitis. The role of highresolution ultrasound. Diabetes Care 1999; 22:294-9. (Pubitemid 29056925)
178. Keidar Z, Militianu D, Melamed E, Bar-Shalom R, Israel O. The diabetic foot: initial experience with 18F-FDG PET/CT. J Nucl Med 2005; 46:444-9. (Pubitemid 43093153)
179. Basu S, Chryssikos T, Houseni M, et al. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and softtissue infection? Nucl Med Commun 2007; 28:465-72. (Pubitemid 46684196)
180. Nawaz A, Torigian DA, Siegelman ES, Basu S, Chryssikos T, Alavi A. Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot. Mol Imaging Biol 2010; 12:335-42.
181. Heiba SI, Kolker D, Mocherla B. The optimized evaluation of diabetic foot infection by dual isotope SPECT/CT imaging protocol. J Foot Ankle Surg 2010; 49:529-36.
182. Sella EJ. Current concepts review: diagnostic imaging of the diabetic foot. Foot Ankle Int 2009; 30:568-76.
183. Berendt AR, Lipsky B. Is this bone infected or not? Differentiating neuro-osteoarthropathy from osteomyelitis in the diabetic foot. Curr Diab Rep 2004; 4:424-9. (Pubitemid 40104218)
184. Ahmadi ME, Morrison WB, Carrino JA, Schweitzer ME, Raikin SM, Ledermann HP. Neuropathic arthropathy of the foot with and without superimposed osteomyelitis: MR imaging characteristics. Radiology 2006; 238:622-31. (Pubitemid 43134375)
185. Berendt AR, Peters EJ, Bakker K, et al. Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev 2008; 24 ,suppl. 1:S145-61. (Pubitemid 351802786)
186. Lipsky BA. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 1997; 25:1318-26. (Pubitemid 28022664)
187. Snyder RJ, Cohen MM, Sun C, Livingston J. Osteomyelitis in the diabetic patient: diagnosis and treatment. Part 2: medical, surgical, and alternative treatments. Ostomy Wound Manage 2001; 47:24-30, 32-41; quiz 42-3.
188. Snyder RJ, CohenMM, Sun C, Livingston J. Osteomyelitis in the diabetic patient: diagnosis and treatment. Part 1: overview, diagnosis, and microbiology. Ostomy Wound Manage 2001; 47:18-22, 25-30; quiz 31-2.
189. Embil JM. The management of diabetic foot osteomyelitis. The Diabetic Foot 2000; 3:76-84.
190. Eckman MH, Greenfield S, Mackey WC, et al. Foot infections in diabetic patients. Decision and cost-effectiveness analyses. JAMA 1995; 273:712-20.
191. Lipsky BA. A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev 2004; 20,suppl. 1:S68-77. (Pubitemid 38714340)
192. Chantelau E, Wolf A, Ozdemir S, Hachmoller A, Ramp U. Bone histomorphology may be unremarkable in diabetes mellitus. Med Klin (Munich) 2007; 102:429-33. (Pubitemid 46981147)
193. Newman LG, Waller J, Palestro CJ, et al. Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. JAMA 1991; 266:1246-51.
194. Lavery LA, Peters EJ, Armstrong DG, Wendel CS, Murdoch DP, Lipsky BA. Risk factors for developing osteomyelitis in patients with diabetic foot wounds. Diabetes Res Clin Pract 2009; 83:347-52.
195. Fleischer AE, Didyk AA, Woods JB, Burns SE, Wrobel JS, Armstrong DG. Combined clinical and laboratory testing improves diagnostic accuracy for osteomyelitis in the diabetic foot. J Foot Ankle Surg 2009; 48:39-46.
196. Rajbhandari SM, Sutton M, Davies C, Tesfaye S, Ward JD. 'Sausage toe': a reliable sign of underlying osteomyelitis. Diabet Med 2000; 17:74-7. (Pubitemid 30094185)
197. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995; 273:721-3.
198. Shone A, Burnside J, Chipchase S, Game F, Jeffcoate W. Probing the validity of the probe-to-bone test in the diagnosis of osteomyelitis of the foot in diabetes. Diabetes Care 2006; 29:945. (Pubitemid 44115325)
199. Lavery LA, Armstrong DG, Peters EJ, Lipsky BA. Probe-to-bone test for diagnosing diabetic foot osteomyelitis: reliable or relic? Diabetes Care 2007; 30:270-4. (Pubitemid 46198329)
200. Hartemann-Heurtier A, Senneville E. Diabetic foot osteomyelitis. Diabetes Metab 2008; 34:87-95.
201. Aragon-Sanchez J, Lipsky BA, Lazaro-Martinez JL. Diagnosing diabetic foot osteomyelitis: is the combination of probe-to-bone test and plain radiography sufficient for high-risk inpatients? Diabet Med 2011; 28:191-4.
202. Morales Lozano R, Gonzalez Fernandez ML, Martinez Hernandez D, Beneit Montesinos JV, Guisado Jimenez S, Gonzalez Jurado MA. Validating the probe-to-bone and other tests for diagnosing chronic osteomyelitis in the diabetic foot. Diabetes Care 2010; 33:2140-45.
203. Lavery LA, Armstrong DG, Harkless LB. Classification of diabetic foot wounds. J Foot Ankle Surg 1996; 35:528-31. (Pubitemid 27023854)
204. Wheat J. Diagnostic strategies in osteomyelitis. Am J Med 1985; 78:218-24. (Pubitemid 15036981)
205. Senneville E, Melliez H, Beltrand E, et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis 2006; 42:57-62. (Pubitemid 41832080)
206. Lesens O, Desbiez F, Vidal M, et al. Culture of per-wound bone specimens: a simplified approach for the medical management of diabetic foot osteomyelitis. Clin Microbiol Infect 2011; 17:285-91.
207. Game F, Jeffcoate W. MRSA and osteomyelitis of the foot in diabetes. Diabet Med 2004; 21(Suppl 4):16-9. (Pubitemid 39215312)
208. Khatri G, Wagner DK, Sohnle PG. Effect of bone biopsy in guiding antimicrobial therapy for osteomyelitis complicating open wounds. Am J Med Sci 2001; 321:367-71. (Pubitemid 33753074)
209. Slater RA, Lazarovitch T, Boldur I, et al. Swab cultures accurately identify bacterial pathogens in diabetic foot wounds not involving bone. Diabet Med 2004; 21:705-9. (Pubitemid 38916214)
210. Zuluaga AF, Galvis W, Jaimes F, Vesga O. Lack of microbiological concordance between bone and non-bone specimens in chronic osteomyelitis: an observational study. BMC Infect Dis 2002; 2:8.
211. Elamurugan TP, Jagdish S, Kate V, Chandra Parija S. Role of bone biopsy specimen culture in the management of diabetic foot osteomyelitis. Int J Surg 2011; 9:214-6.
212. Kessler L, Piemont Y, Ortega F, et al. Comparison of microbiological results of needle puncture vs. superficial swab in infected diabetic foot ulcer with osteomyelitis. Diabet Med 2006; 23:99-102.
213. Senneville E, Morant H, Descamps D, et al. Needle puncture and transcutaneous bone biopsy cultures are inconsistent in patients with diabetes and suspected osteomyelitis of the foot. Clin Infect Dis 2009; 48:888-93.
214. Bernard L, Uckay I, Vuagnat A, et al. Two consecutive deep sinus tract cultures predict the pathogen of osteomyelitis. Int J Infect Dis 2010; 14:e390-3.
215. Ertugrul MB, Baktiroglu S, Salman S, et al. The diagnosis of osteomyelitis of the foot in diabetes: microbiological examination vs. magnetic resonance imaging and labelled leucocyte scanning. Diabet Med 2006; 23:649-53. (Pubitemid 43830066)
216. Howard CB, Einhorn M, Dagan R, Yagupski P, Porat S. Fine-needle bone biopsy to diagnose osteomyelitis. J Bone Joint Surg Br 1994; 76:311-4. (Pubitemid 24083256)
217. Tan JS, File TM Jr. Diagnosis and treatment of diabetic foot infections. Baillieres Best Pract Res Clin Rheumatol 1999; 13:149-61. (Pubitemid 29521031)
218. Mader JT, Ortiz M, Calhoun JH. Update on the diagnosis and management of osteomyelitis. Clin Podiatr Med Surg 1996; 13:701-24. (Pubitemid 26362674)
219. Marschall J, Bhavan KP, Olsen MA, Fraser VJ, Wright NM, Warren DK. The impact of prebiopsy antibiotics on pathogen recovery in hematogenous vertebral osteomyelitis. Clin Infect Dis 2011; 52:867-72.
220. White LM, Schweitzer ME, Deely DM, Gannon F. Study of osteomyelitis: utility of combined histologic and microbiologic evaluation of percutaneous biopsy samples. Radiology 1995; 197:840-2.
221. Senneville E, Lombart A, Beltrand E, et al. Outcome of diabetic foot osteomyelitis treated nonsurgically: a retrospective cohort study. Diabetes Care 2008; 31:637-42.
222. Weiner RD, Viselli SJ, Fulkert KA, Accetta P. Histology versus microbiology for accuracy in identification of osteomyelitis in the diabetic foot. J Foot Ankle Surg 2011; 50:197-200.
223. Sella EJ, Grosser DM. Imaging modalities of the diabetic foot. Clin Podiatr Med Surg 2003; 20:729-40. (Pubitemid 37377353)
224. Chatha DS, Cunningham PM, Schweitzer ME. MR imaging of the diabetic foot: diagnostic challenges. Radiol Clin North Am 2005; 43:747-59, ix. (Pubitemid 40704721)
225. Termaat MF, Raijmakers PG, Scholten HJ, Bakker FC, Patka P, Haarman HJ. The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis. J Bone Joint Surg Am 2005; 87:2464-71. (Pubitemid 41546377)
226. Peterson LR, Lissack LM, Canter K, Fasching CE, Clabots C, Gerding DN. Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. Am J Med 1989; 86:801-8. (Pubitemid 19148097)
227. Ha Van G, Siney H, Danan JP, Sachon C, Grimaldi A. Treatment of osteomyelitis in the diabetic foot. Contribution of conservative surgery. Diabetes Care 1996; 19:1257-60.
228. Venkatesan P, Lawn S, Macfarlane RM, Fletcher EM, Finch RG, Jeffcoate WJ. Conservative management of osteomyelitis in the feet of diabetic patients. Diabet Med 1997; 14:487-90. (Pubitemid 27286522)
229. Senneville E, Yazdanpanah Y, Cazaubiel M, et al. Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. J Antimicrob Chemother 2001; 48:927-30. (Pubitemid 33735334)
230. Pittet D, Wyssa B, Herter-Clavel C, Kursteiner K, Vaucher J, Lew PD. Outcome of diabetic foot infections treated conservatively: a retrospective cohort study with long-term follow-up. Arch Intern Med 1999; 159:851-6. (Pubitemid 29200312)
231. Yadlapalli N, Vaishnar A, Sheehan P. Conservative management of diabetic foot ulcers complicated by osteomyelitis. Wounds 2002; 14:31-5. (Pubitemid 41510718)
232. Bamberger DM, Daus GP, Gerding DN. Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy. Am J Med 1987; 83:653-60.
233. Nix DE, Cumbo TJ, Kuritzky P, DeVito JM, Schentag JJ. Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics. Am J Med 1987; 82:146-53.
234. Embil JM, Rose G, Trepman E, et al. Oral antimicrobial therapy for diabetic foot osteomyelitis. Foot Ankle Int 2006; 27:771-9. (Pubitemid 44497843)
235. Yamaguchi Y, Yoshida S, Sumikawa Y, et al. Rapid healing of intractable diabetic foot ulcers with exposed bones following a novel therapy of exposing bone marrow cells and then grafting epidermal sheets. Br J Dermatol 2004; 151:1019-28. (Pubitemid 39573890)
236. Game FL, Jeffcoate WJ. Primarily non-surgical management of osteomyelitis of the foot in diabetes. Diabetologia 2008; 51:962-7.
237. Roeder B, Van Gils CC, Maling S. Antibiotic beads in the treatment of diabetic pedal osteomyelitis. J Foot Ankle Surg 2000; 39:124-30. (Pubitemid 30226939)
238. Wininger DA, Fass RJ. Antibiotic-impregnated cement and beads for orthopedic infections. Antimicrob Agents Chemother 1996; 40:2675-9. (Pubitemid 26404324)
239. Yamashita Y, Uchida A, Yamakawa T, Shinto Y, Araki N, Kato K. Treatment of chronic osteomyelitis using calcium hydroxyapatite ceramic implants impregnated with antibiotic. Int Orthop 1998; 22:247-51. (Pubitemid 28464133)
240. Jacobs AM, Seifert AM, Kirisits TJ, Protzel HR. Use of antibioticloaded bone cement in the management of common infections of the foot and ankle. Clin Podiatr Med Surg 1990; 7:523-44. (Pubitemid 20277453)
241. Marvaso A, Esposito S, Noviello S, et al. [Outpatient parenteral antibiotic therapy (OPAT) of diabetic foot infections with piperacillin/ tazobactam]. Infez Med 2002; 10:230-5. (Pubitemid 36142729)
242. Barth RE, Vogely HC, Hoepelman AI, Peters EJ. 'To bead or not to bead?' Treatment of osteomyelitis and prosthetic joint-associated infections with gentamicin bead chains. Int J Antimicrob Agents 2011; 38:371-5.
243. Fox HR, Karchmer AW. Management of diabetic foot infections, including the use of home intravenous antibiotic therapy. Clin Podiatr Med Surg 1996; 13:671-82. (Pubitemid 26362672)
244. Tice AD, Hoaglund PA, Shoultz DA. Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy. Am J Med 2003; 114:723-8. (Pubitemid 36776353)
245. Steffen C, O'Rourke S. Surgical management of diabetic foot complications: the Far North Queensland profile. Aust N Z J Surg 1998; 68:258-60. (Pubitemid 28179317)
246. Giurini JM, Rosenblum BI. The role of foot surgery in patients with diabetes. Clin Podiatr Med Surg 1995; 12:119-27.
247. Bridges RM Jr, Deitch EA. Diabetic foot infections. Pathophysiology and treatment. Surg Clin North Am 1994; 74:537-55.
248. Gill LH. Foot surgery in the patient with diabetes. J South Orthop Assoc 1994; 3:261-7.
249. Chaytor ER. Surgical treatment of the diabetic foot. Diabetes Metab Res Rev 2000; 16,suppl. 1:S66-9.
250. Scher KS, Steele FJ. The septic foot in patients with diabetes. Surgery 1988; 104:661-6.
251. Pinzur MS, Sage R, Abraham M, Osterman H. Limb salvage in infected lower extremity gangrene. Foot Ankle 1988; 8:212-5. (Pubitemid 18096486)
252. Armstrong DG, Perales TA, Murff RT, Edelson GW, Welchon JG. Value of white blood cell count with differential in the acute diabetic foot infection. J Am Podiatr Med Assoc 1996; 86:224-7. (Pubitemid 126671368)
253. Lavery LA, Armstrong DG, Quebedeaux TL, Walker SC. Puncture wounds: normal laboratory values in the face of severe infection in diabetics and non-diabetics. Am J Med 1996; 101:521-5. (Pubitemid 126335973)
254. Tan JS, Friedman NM, Hazelton-Miller C, Flanagan JP, File TM Jr. Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation? Clin Infect Dis 1996; 23:286-91. (Pubitemid 26264911)
255. Armstrong DG, Lipsky BA. Diabetic foot infections: stepwise medical and surgical management. Int Wound J 2004; 1:123-32.
256. Grodinsky M. A study of the fascial spaces of the foot and their bearing on infections. 1929:737-43.
257. Loeffler RD Jr, Ballard A. Plantar fascial spaces of the foot and a proposed surgical approach. Foot Ankle 1980; 1:11-4. (Pubitemid 11063494)
258. Piaggesi A, Schipani E, Campi F, et al. Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomized trial. Diabet Med 1998; 15:412-7. (Pubitemid 28197110)
259. Bose K. A surgical approach for the infected diabetic foot. Int Orthop 1979; 3:177-81. (Pubitemid 10207933)
260. Brodsky JW, Schneidler C. Diabetic foot infections. Orthop Clin North Am 1991; 22:473-89.
261. Connolly JE, Wrobel JS, Anderson RF. Primary closure of infected diabetic foot wounds. A report of closed instillation in 30 cases. J Am Podiatr Med Assoc 2000; 90:175-82.
262. Pinzur MS. Amputation level selection in the diabetic foot. Clin Orthop Relat Res 1993:68-70. (Pubitemid 23332119)
263. Armstrong DG, Lavery LA, Frykberg RG, Wu SC, Boulton AJ. Validation of a diabetic foot surgery classification. Int Wound J 2006; 3:240-6.
264. Durham JR, McCoy DM, Sawchuk AP, et al. Open transmetatarsal amputation in the treatment of severe foot infections. Am J Surg 1989; 158:127-30. (Pubitemid 19206332)
265. Benton GS, Kerstein MD. Cost effectiveness of early digit amputation in the patient with diabetes. Surg Gynecol Obstet 1985; 161:523-4. (Pubitemid 16172269)
266. Field CK, Kerstein MD. Cost-benefit analysis of lower-extremity amputation: ethical considerations. Wounds 1993; 5:10-3.
267. Van Damme H, Rorive M, Martens De Noorthout BM, Quaniers J, Scheen A, Limet R. Amputations in diabetic patients: a plea for footsparing surgery. Acta Chir Belg 2001; 101:123-9. (Pubitemid 33633246)
268. Khammash MR, Obeidat KA. Prevalence of ischemia in diabetic foot infection. World J Surg 2003; 27:797-9. (Pubitemid 37022391)
269. Wrobel JS, Robbins J, Armstrong DG. The high-low amputation ratio: a deeper insight into diabetic foot care? J Foot Ankle Surg 2006; 45:375-9. (Pubitemid 44827790)
270. Jones V. Debridement of diabetic foot lesions. The Diabetic Foot 1998; 1:88-94.
271. Rauwerda JA. Foot debridement: anatomic knowledge is mandatory. Diabetes Metab Res Rev 2000; 16,suppl. 1:S23-6.
272. Lepantalo M, Biancari F, Tukiainen E. Never amputate without consultation of a vascular surgeon. Diabetes Metab Res Rev 2000; 16,suppl. 1:S27-32.
273. LoGerfo FW, Coffman JD. Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care. N Engl J Med 1984; 311:1615-9. (Pubitemid 15175203)
274. Holstein PE, Sorensen S. Limb salvage experience in a multidisciplinary diabetic foot unit. Diabetes Care 1999; 22(Suppl 2):B97-103. (Pubitemid 29107157)
275. Estes JM, Pomposelli FB Jr. Lower extremity arterial reconstruction in patients with diabetes mellitus. Diabet Med 1996; 13,suppl. 1: S43-7.
276. Chang BB, Darling RC 3rd, Paty PS, Lloyd WE, Shah DM, Leather RP. Expeditious management of ischemic invasive foot infections. Cardiovasc Surg 1996; 4:792-5. (Pubitemid 27061912)
277. Taylor LM Jr, Porter JM. The clinical course of diabetics who require emergent foot surgery because of infection or ischemia. J Vasc Surg 1987; 6:454-9.
278. Steed DL, Donohoe D, Webster MW, Lindsley L. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg 1996; 183:61-4. (Pubitemid 26234895)
279. Vermeulen H, Ubbink D, Goossens A, de Vos R, Legemate D. Dressings and topical agents for surgical wounds healing by secondary intention. Cochrane Database Syst Rev 2004; 2:CD003554.
280. Ubbink DT, Westerbos SJ, Evans D, Land L, Vermeulen H. Topical negative pressure for treating chronic wounds. Cochrane Database Syst Rev 2008; 3:CD001898.
281. Vermeulen H, van Hattem JM, Storm-Versloot MN, Ubbink DT. Topical silver for treating infected wounds. Cochrane Database Syst Rev 2007; 1:CD005486.
282. Bergin SM, Wraight P. Silver based wound dressings and topical agents for treating diabetic foot ulcers. Cochrane Database Syst Rev 2006; 1:CD005082.
283. Hinchliffe RJ, Valk GD, Apelqvist J, et al. A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev 2008; 24 ,suppl. 1:S119-44. (Pubitemid 351802785)
284. Hilton JR, Williams DT, Beuker B, Miller DR, Harding KG. Wound dressings in diabetic foot disease. Clin Infect Dis 2004; 39(Suppl 2): S100-3. (Pubitemid 39050505)
285. Nelson EA, O'Meara S, Golder S, Dalton J, Craig D, Iglesias C. Systematic review of antimicrobial treatments for diabetic foot ulcers. Diabet Med 2006; 23:348-59.
286. O'Meara SM, Cullum NA, Majid M, Sheldon TA. Systematic review of antimicrobial agents used for chronic wounds. Br J Surg 2001; 88:4-21. (Pubitemid 32066051)
287. Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg 2006; 117:143S-149S; discussion 50S-51S. (Pubitemid 44317778)
288. Apelqvist J, Bakker K, van Houtum WH, Schaper NC. Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) Prepared by the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 2008; 24,suppl. 1:S181-7.
289. Driver VR. Treating the macro and micro wound environment of the diabetic patient: managing the whole patient, not the hole in the patient. 2004:49-56.
290. Svensjo T, Pomahac B, Yao F, Slama J, Eriksson E. Accelerated healing of full-thickness skin wounds in a wet environment. Plast Reconstr Surg 2000; 106:602-12; discussion 13-4. (Pubitemid 30666301)
291. Smith J, Thow J. Is debridement effective for diabetic foot ulcers? A systematic review: 2. The Diabetic Foot 2001; 4:77-80.
292. Smith J. Is debridement effective for diabetic foot ulcer? A systematic review: 1. The Diabetic Foot 2001; 1:10-4.
293. Eldor R, Raz I, Ben Yehuda A, Boulton AJ. New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies. Diabet Med 2004; 21:1161-73. (Pubitemid 39472370)
294. Cutting K, White R, Edmonds M. The safety and efficacy of dressings with silver-addressing clinical concerns. IntWound J 2007; 4:177-84.
295. Chopra I. The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? J Antimicrob Chemother 2007; 59:587-90. (Pubitemid 47073388)
296. Percival SL, Woods E, Nutekpor M, Bowler P, Radford A, Cochrane C. Prevalence of silver resistance in bacteria isolated from diabetic foot ulcers and efficacy of silver-containing wound dressings. Ostomy Wound Manage 2008; 54:30-40.
297. Silver dressings for the treatment of patients with infected wounds: a review of clinical and cost-effectiveness. Health Technology Inquiry Service, 2010.
298. Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. Topical silver for preventing wound infection. Cochrane Database Syst Rev 2010; 3:CD006478.
299. Armstrong DG, Nguyen HC, Lavery LA, van Schie CH, Boulton AJ, Harkless LB. Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 2001; 24:1019-22. (Pubitemid 33716369)
300. Lewis R, Whiting P, ter Riet G, O'Meara S, Galanville J. A rapid systematic review of the clinical effectiveness and cost effectiveness of debriding agents in treating surgical wounds healing by secondary intention. NHS HTA Programme, the National Institute of Clinical Excellence, NHS Centre for Reviews and Dissemination: University of York, 2000:1-8.
301. Armstrong DG, Lavery LA, Vazquez JR, Nixon BP, Boulton AJ. How and why to surgically debride neuropathic diabetic foot wounds. J Am Podiatr Med Assoc 2002; 92:402-4. (Pubitemid 44178794)
302. Singhal A, Reis ED, Kerstein MD. Options for nonsurgical debridement of necrotic wounds. Adv Skin Wound Care 2001; 14:96-100; quiz 02-3.
303. Attinger CE, Janis JE, Steinberg J, Schwartz J, Al-Attar A, Couch K. Clinical approach to wounds: debridement and wound bed preparation including the use of dressings and wound-healing adjuvants. Plast Reconstr Surg 2006; 117:72S-109S. (Pubitemid 44317773)
304. Attinger CE, Bulan E, Blume PA. Surgical debridement. The key to successful wound healing and reconstruction. Clin Podiatr Med Surg 2000; 17:599-630.
305. Tantawi TI, Gohar YM, Kotb MM, Beshara FM, El-Naggar MM. Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers. J Wound Care 2007; 16:379-83.
306. Paul AG, Ahmad NW, Lee HL, et al. Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers. Int Wound J 2009; 6:39-46.
307. Lodge A, Jones M, Thomas S. Maggots 'n' chips: a novel approach to the treatment of diabetic ulcers. Br J Community Nurs 2006; 11 (Suppl):23-6.
308. Edwards J, Stapley S. Debridement of diabetic foot ulcers. Cochrane Database Syst Rev 2010; 4:CD003556.
309. Sainsbury DC. Evaluation of the quality and cost-effectiveness of Versajet hydrosurgery. Int Wound J 2009; 6:24-9.
310. Caputo WJ, Beggs DJ, DeFede JL, Simm L, Dharma H. A prospective randomised controlled clinical trial comparing hydrosurgery debridement with conventional surgical debridement in lower extremity ulcers. Int Wound J 2008; 5:288-94. (Pubitemid 351731679)
311. Cavanagh PR. Therapeutic footwear for people with diabetes. Diabetes Metab Res Rev 2004; 20,suppl. 1:S51-5. (Pubitemid 38714337)
312. Mueller MJ, Diamond JE, Sinacore DR, et al. Total contact casting in treatment of diabetic plantar ulcers. Controlled clinical trial. Diabetes Care 1989; 12:384-8. (Pubitemid 19140657)
313. Bus SA, Valk GD, van Deursen RW, et al. The effectiveness of footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in diabetes: a systematic review. Diabetes Metab Res Rev 2008; 24 ,suppl. 1:S162-80. (Pubitemid 351802787)
314. Katz IA, Harlan A, Miranda-Palma B, et al. A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care 2005; 28:555-9. (Pubitemid 40315312)
315. Nabuurs-Franssen MH, Sleegers R, Huijberts MS, et al. Total contact casting of the diabetic foot in daily practice: a prospective follow-up study. Diabetes Care 2005; 28:243-7. (Pubitemid 40170920)
316. Frykberg RG, Zgonis T, Armstrong DG, et al. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg 2006; 45:S1-66. (Pubitemid 46187108)
317. Cavanagh PR, Lipsky BA, Bradbury AW, Botek G. Treatment for diabetic foot ulcers. Lancet 2005; 366:1725-35. (Pubitemid 41587453)
318. Spencer S. Pressure relieving interventions for preventing and treating diabetic foot ulcers. Cochrane Database Syst Rev 2000; 3:CD002302.
319. Cardinal M, Eisenbud DE, Phillips T, Harding K. Early healing rates and wound area measurements are reliable predictors of later complete wound closure. Wound Repair Regen 2008; 16:19-22.
320. Ince P, Game FL, Jeffcoate WJ. Rate of healing of neuropathic ulcers of the foot in diabetes and its relationship to ulcer duration and ulcer area. Diabetes Care 2007; 30:660-3. (Pubitemid 46354349)
321. Chuck AW, Hailey D, Jacobs P, Perry DC. Cost-effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers. Int J Technol Assess Health Care 2008; 24:178-83. (Pubitemid 351519517)
322. Goldman RJ. Hyperbaric oxygen therapy for wound healing and limb salvage: a systematic review. PM R 2009; 1:471-89.
323. Kranke P, Bennett M, Roeckl-Wiedmann I, Debus S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2004; 2:CD004123.
324. Lipsky BA, Berendt AR. Hyperbaric oxygen therapy for diabetic foot wounds: has hope hurdled hype? Diabetes Care 2010; 33:1143-5.
325. Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care 1998; 21:822-7. (Pubitemid 28487079)
326. Robson M. Integrating the results of phase IV (postmarketing) clinical trial with four previous trials reinforces the position of Regranex (becaplermin) gel 0.01% is an effective adjunct to the treatment of diabetic foot ulcer. J Appl Res 2005; 5:35-45.
327. Viswanathan V, Mahesh U, Jayaraman M, Shina K, Ramachandram A. Beneficial role of granulocyte colony stimulating factor in foot infection in diabetic patients. J Assoc Physicians India 2003; 51:90-1.
328. Gough A, Clapperton M, Rolando N, Foster AV, Philpott-Howard J, Edmonds ME. Randomised placebo-controlled trial of granulocytecolony stimulating factor in diabetic foot infection. Lancet 1997; 350:855-9. (Pubitemid 27404347)
329. de Lalla F, Pellizzer G, Strazzabosco M, et al. Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrob Agents Chemother 2001; 45:1094-8. (Pubitemid 32230987)
330. Yonem A, Cakir B, Guler S, Azal OO, Corakci A. Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection. Diabetes Obes Metab 2001; 3:332-7. (Pubitemid 33076727)
331. Kastenbauer T, Hornlein B, Sokol G, Irsigler K. Evaluation of granulocyte-colony stimulating factor (Filgrastim) in infected diabetic foot ulcers. Diabetologia 2003; 46:27-30. (Pubitemid 36237743)
332. Huang P, Li S, Han M, Xiao Z, Yang R, Han ZC. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 2005; 28:2155-60. (Pubitemid 41242461)
333. Cruciani M, Lipsky BA, Mengoli C, de Lalla F. Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections. Cochrane Database Syst Rev 2009; 3:CD006810.
334. Gentzkow GD, Iwasaki SD, Hershon KS, et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996; 19:350-4. (Pubitemid 26115458)
335. Naughton G, Mansbridge J, Gentzkow G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif Organs 1997; 21:1203-10. (Pubitemid 27504988)
336. Marston WA, Hanft J, Norwood P, Pollak R. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 2003; 26:1701-5. (Pubitemid 36929107)
337. Blume PA, Walters J, Payne W, Ayala J, Lantis J. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care 2008; 31:631-6.
338. Armstrong DG, Lavery LA. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 2005; 366:1704-10. (Pubitemid 41587449)
339. Wu SC, Marston W, Armstrong DG. Wound care: the role of advanced wound-healing technologies. J Am Podiatr Med Assoc 2010; 100:385-94.
340. Gregor S, Maegele M, Sauerland S, Krahn JF, Peinemann F, Lange S. Negative pressure wound therapy: a vacuum of evidence? Arch Surg 2008; 143:189-96. (Pubitemid 351281632)
341. Fincke BG, Miller DR, Turpin R. A classification of diabetic foot infections using ICD-9-CM codes: application to a large computerized medical database. BMC Health Serv Res 2010; 10:192.
342. Fincke BG, Miller DR, Christiansen CL, Turpin RS. Variation in antibiotic treatment for diabetic patients with serious foot infections: a retrospective observational study. BMC Health Serv Res 2010; 10:193.
343. Sotto A, Richard JL, Combescure C, et al. Beneficial effects of implementing guidelines on microbiology and costs of infected diabetic foot ulcers. Diabetologia 2010; 53:2249-55.
344. Jeffcoate WJ, Chipchase SY, Ince P, Game FL. Assessing the outcome of the management of diabetic foot ulcers using ulcerrelated and person-related measures. Diabetes Care 2006; 29: 1784-7. (Pubitemid 44156630)
345. Kimsey DB. Lean methodology in health care. AORN J 2010; 92:53-60.